ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DNL Diurnal Group Plc

27.30
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Diurnal Group Plc LSE:DNL London Ordinary Share GB00BDB6Q760 ORD GBP0.05
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 27.30 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Diurnal Group PLC Director Dealings (3933U)

17/01/2017 3:30pm

UK Regulatory


Diurnal (LSE:DNL)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Diurnal Charts.

TIDMDNL

RNS Number : 3933U

Diurnal Group PLC

17 January 2017

17 January 2017

Diurnal Group plc

("Diurnal" or the "Company")

Director Dealings

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, received notification of the following purchase of shares by a person closely associated to a Company Director on 16 January 2017:

Mrs Lynne Raymond, wife of Alan Raymond, Non-executive Director, purchased 9,000 ordinary shares of 5.0 pence each in the Company ("Ordinary Shares") at a price of 110 pence per Ordinary Share. Following the transaction, Alan Raymond and his connected parties have a total interest of 22,888 Ordinary Shares, representing 0.04% of the total voting rights.

 
 For further information, please visit www.diurnal.co.uk 
  or contact: 
 
                                           +44 (0)20 3727 
 Diurnal Group plc                          1000 
 Martin Whitaker, CEO 
 Richard Bungay, CFO 
 
 Numis Securities Ltd (Nominated           +44 (0)20 7260 
  Adviser)                                  1000 
 Nominated Adviser: Michael Meade, 
  Freddie Barnfield, Paul Gillam 
 Corporate Broking: James Black 
 
                                           +44 (0)20 3727 
 FTI Consulting                             1000 
 Simon Conway 
 Victoria Foster Mitchell 
 

Notes to Editors

About Diurnal Group plc

Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visit www.diurnal.co.uk

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 
      Details of the person discharging managerial 
       responsibilities/person closely associated 
---  -------------------------------------------------------------- 
 a)   Name:                              Lynne Ryamond 
---  ---------------------------------  --------------------------- 
      Reason for the notification 
---  -------------------------------------------------------------- 
 a)   Position/status:                   Closely associated 
                                          person to a Non-Executive 
                                          Director 
---  ---------------------------------  --------------------------- 
 b)   Initial notification/Amendment:    Initial 
---  ---------------------------------  --------------------------- 
      Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  -------------------------------------------------------------- 
 a)   Name:                              Diurnal Group plc 
---  ---------------------------------  --------------------------- 
 b)   LEI:                               n/a 
---  ---------------------------------  --------------------------- 
      Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------------------- 
 a)   Description of the financial       Ordinary shares of 
       instrument, type of instrument:    5p each. 
 
       Identification code: 
                                          GB00BDB6Q760 
---  ---------------------------------  --------------------------- 
 b)   Nature of the transaction:         Purchase 
---  ---------------------------------  --------------------------- 
 c)   Price(s) and volume(s):             Price(s)   Volume(s) 
                                          ---------  ---------- 
                                           110p       9,000 
                                          ---------  ---------- 
---  ---------------------------------  --------------------------- 
 d)   Aggregated information:            Aggregated volume: 
                                          9,000 
 
                                          Price: GBP9,900.00 
---  ---------------------------------  --------------------------- 
 e)   Date of the transaction:           16 January 2017 
---  ---------------------------------  --------------------------- 
 f)   Place of the transaction:          XLON 
---  ---------------------------------  --------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFFELTIDLID

(END) Dow Jones Newswires

January 17, 2017 10:30 ET (15:30 GMT)

1 Year Diurnal Chart

1 Year Diurnal Chart

1 Month Diurnal Chart

1 Month Diurnal Chart

Your Recent History

Delayed Upgrade Clock